Intraoperative Radiotherapy for Breast Cancer in Elderly Women

被引:4
|
作者
Guillerm, S. Ophie [1 ,2 ]
Bourstyn, Edwige [1 ,2 ]
Itti, Ramona [1 ,2 ]
Cahen-Doidy, Laurence [1 ,2 ]
Quero, Laurent [1 ,2 ]
Labidi, Mouna [1 ,2 ]
Marchand, Eva [1 ,2 ]
Lorphelin, Henri [1 ,2 ]
Giacchetti, Sylvie [1 ,2 ]
Cuvier, Caroline [1 ,2 ]
Espie, Marc [1 ,2 ]
Teixeira, Luis [1 ,2 ]
Hennequin, Christophe [1 ,2 ]
机构
[1] St Louis Hosp, Radiat Oncol Dept, Paris, France
[2] St Louis Hosp, Breast Canc Unit, Paris, France
关键词
Breast cancer; Intraoperative radiotherapy; Local control; Cosmetic result; LUMPECTOMY PLUS TAMOXIFEN; KILOVOLTAGE X-RAYS; CONSENSUS STATEMENT; CONSERVING SURGERY; RADIATION-THERAPY; IRRADIATION; RECURRENCE; OLDER; METAANALYSIS; MORTALITY;
D O I
10.1016/j.clbc.2021.05.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Intraoperative radiotherapy (IORT) with low-energy photons was delivered to 191 women >65 years of age. Only 8 patients had postoperative external beam radiotherapy. 5-year local relapse rate was 1.7%. Postoperative complications were rare, without delay in wound healing, even in older women. Cosmetic result was good or excellent in >90% of the patients. Purpose: To evaluate outcomes and postoperative toxicities after intraoperative radiotherapy (IORT) in elderly women. Population: Women older than 65 years, with infiltrating ductal breast cancer <= 3 cm, expressing estrogen receptor (ER+) without Her2 overexpression, and with negative axillary nodes. Treatment: Treatment consisted of partial mastectomy with a sentinel lymph node biopsy (SLNB) procedure; in case of positive SLNB, IORT was cancelled. IORT consisted in a total dose of 20 Gy in 1 fraction delivered at the surface of the applicator with the Intrabeam (R) technique. Results: IORT was planned to be administered to a total of 225 patients but was cancelled for 34 patients during surgery. Thus 191 patients were analyzed; mean age was 76 years, with 57 patients (30%) >80 years. Despite inclusion criteria, 15 had lobular carcinoma and 7 were triple negative. With a median follow-up of 40 months, we observed only 1 local recurrence, located in the skin over the initial tumor. The 5-year local relapse rate was 1.7%. A wound healing delay ( >15 days) was observed in 21 patients (11%). Sixty-six patients (35%) had postoperative complications, mainly grade 2, resolving within a few days. Two patients needed surgical drainage for local abscesses. Long-term ( >1 year) cosmetic outcome was evaluated in 120 patients and was judged excellent or good in 102 (91%). Conclusion: IORT can be safely given to elderly women, with a good local control rate and without major toxicities. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:E109 / E113
页数:5
相关论文
共 50 条
  • [41] Initiation of an Intraoperative Radiotherapy Program at a Safety net Hospital: What Is the Impact of an Intraoperative Radiotherapy Program in Underserved Patients With Early Breast Cancer?
    Lalchandani, Priti
    Sila, Chad
    Ozao-Choy, Junko
    Dauphine, Christine
    AMERICAN SURGEON, 2021, 87 (05) : 833 - 838
  • [42] Tamoxifen with radiotherapy compared with Tamoxifen alone in elderly women with early-stage breast cancer treated with breast conserving surgery: A systematic review and meta-analysis
    Chesney, Tyler R.
    Yin, Jennifer Xin
    Rajaee, Nikoo
    Tricco, Andrea C.
    Fyles, Anthony W.
    Acuna, Sergio A.
    Scheer, Adena S.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 (01) : 1 - 9
  • [43] Adjuvant radiotherapy for low-risk early breast cancer in elderly women: evidence from randomized trials
    Burgos-Burgos, Javier
    Pinar-Sedeno, Beatriz
    Garcia-Cabrera, Laura
    Rodriguez-Ibarria, Nieves
    Cabezon-Pons, Auxiliadora
    Lloret-Saenz-Bravo, Marta
    Vicente-Rubio, Elena
    Vega-Benitez, Victor
    Travieso-Aja, Maria
    Lara, Pedro C.
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 : S207 - S216
  • [44] Efficacy analysis of intraoperative radiotherapy in patients with early-stage breast cancer
    Wang, Lin
    Zhu, Minmin
    Cui, Yuelong
    Zhang, Xudong
    Li, Guowen
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [45] Phase I/II study of intraoperative radiotherapy for early breast cancer in Japan
    Sawaki, Masataka
    Sato, Shigenori
    Noda, Sumiyo
    Idota, Ai
    Uchida, Hiroki
    Tsunoda, Nobuyuki
    Kikumori, Toyone
    Aoyama, Yuichi
    Ishihara, Shunichi
    Itoh, Yoshiyuki
    Imai, Tsuneo
    BREAST CANCER, 2012, 19 (04) : 353 - 359
  • [46] Up to 5 years outcomes following intraoperative radiotherapy for early breast cancer
    d'Illiers, Laurence Bauwens Patas
    Lafay, Frederic
    Faure, Christelle
    Klingler, Sophie
    Pleynet, Elodie
    Racadot, Severine
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 (04) : 859 - 870
  • [47] Postoperative cosmetic outcome of intraoperative radiotherapy in comparison to whole breast radiotherapy in early stage breast cancer; a retrospective cohort study
    Nafissi, Nahid
    Meshkati Yazd, Seyed Mostafa
    Shahriarirad, Reza
    Zangeneh, Saba
    Ghorbani, Sahar
    Farazmand, Borna
    Karoobi, Mohammadreza
    Mirzaei, Hamid Reza
    BMC CANCER, 2023, 23 (01)
  • [48] Intraoperative Boost Radiotherapy with 50 kV X-Rays Versus External Radiotherapy in Breast Cancer: Single-Center Experiences
    Moini, Nazi
    Akbari, Mohammad Esmaeil
    Mirzaei, Hamidreza
    Daghigh, Seyed Mohsen Hosseini
    Zayeri, Farid
    Hajizadeh, Nastaran
    Hajian, Parastoo
    Malekzadeh, Mona
    INTERNATIONAL JOURNAL OF CANCER MANAGEMENT, 2020, 13 (03)
  • [49] Radiation Oncologists' Views on Adjuvant Radiotherapy for Early-Stage Breast Cancer in the Elderly: Comparisons between Japan and the United States
    Kuwatsuru, Yoshiki
    Saito, Anneyuko I.
    Usui, Keisuke
    CANCER INVESTIGATION, 2024, 42 (04) : 309 - 318
  • [50] Single-dose intraoperative radiotherapy during lumpectomy for breast cancer: an innovative patient-centred treatment
    Vaidya, Jayant S.
    Bulsara, Max
    Baum, Michael
    Tobias, Jeffrey S.
    BRITISH JOURNAL OF CANCER, 2021, 124 (09) : 1469 - 1474